Compagnie Gervais Danone

Agusti Montserrat Carreras

Stephane Doat

Ricardo Weill

Elena Vela Roca

Claude Emmanuelle Gaspard

Bernard Robine

Daniel Ramon Vidal

Salvador Genoves Martinez

Esther Bataller Leiva

Montserrat Andreu Corominas

The present invention discloses strains ofandwhich have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.

Lactic acid bacteria for coeliac disease

A method for preparing a dairy product in a production line, includes a step of continuously injecting at least one sterol and/or stanol ester through the production line at a predetermined temperature Tno lower than the melting point of the ester, and particularly at a temperature of 35-80&#xb0; C., and into a dairy composition at a predetermined temperature Tno lower than the temperature T, which composition consists of an initial emulsifier-free milk-based composition containing milk proteins, to give a mixture, wherein the step of injecting at least one sterol and/or stanol ester is carried out before a step of homogenizing the mixture.

Method for preparing a dairy product

Growing community of inventors

Barcelona, Spain

Agusti Montserrat Carreras